Maven Securities LTD Seres Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$2.7 - $7.62 $3.12 Million - $8.8 Million
1,154,507 New
1,154,507 $3.96 Million
Q4 2019

Feb 14, 2020
SELL
$2.99 - $4.42 $299,000 - $442,000
-100,000 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$2.29 - $4.16 $148,927 - $270,541
-65,034 Reduced 39.41%
100,000 $395,000
Q2 2019

Aug 13, 2019
BUY
$2.28 - $7.35 $376,277 - $1.21 Million
165,034 New
165,034 $526,000

Others Institutions Holding MCRB

# of Institutions
79
Shares Held
41M
Call Options Held
304K
Put Options Held
471K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $104M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email